• The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
  • This web site is a service of Prostate Cancer International.

    pcai_cmyk

  • Other PCI web sites

  • The "New" Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services.

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

    • Perspective Confidentiality Disclosure Reliability Courtesy

Prostate cancer news reports: Friday, November 13, 2009


In today’s prostate cancer news reports we have noted items on:

  • The Prostate Cancer Risk Calculator and its use in community practice
  • Potential guidelines on prostate cancer management for the elderly
  • The relative risk of single focus as compared to multifocal disease

Eyre et al. have validated the accuracy of the PCPT-based Prostate Cancer Risk Calulator in the diagnosis of prostate cancer in a community-based setting that is highly representative of patients referred for consideration of prostate biopsy in American urology practices.

On behalf of the International Society of Geriatric Oncology (SIOG), Droz et al. have outlined principles for the development of a set of guidelines for management of prostate cancer in men over 70 years of age. The basic premise behind such guidelines is that the treatment of prostate cancer in senior adults should be adapted to the health status of the individual patient.

Rice et al. have reported that, based on an analysis of prostate cancer patients records in the database of the Center for Prostate Disease Research (CPDR), single focus prostate cancer occurs in about 9 percent of patients (103/1,159) and is significantly more aggressive than multifocal disease. Single focus prostate cancer was also associated with statistically higher rates of positive surgical margins, Gleason score 8-10 disease, and biochemical recurrence than multifocal disease.

One Response

  1. This news is very encouraging for us Councilors, but the most surprising facts supplied to a recent forum last week here in Australia by the Cancer Council of Australia is that prostate cancer is now the number 1 cause in both genders. This is the link: see page 12.

Leave a Reply